hbv cure workshop (Denver, CO, USA)

The 13th International HBV Cure Workshop is scheduled to be held in Denver, Colorado right before AASLD. This workshop also brings together global inter-disciplinary experts to provide a framework for how academia and industry should collaborate to achieve the goal of curing hepatitis B.

The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. Annually, the AASLD hosts The Liver Meeting (TLM), with 8,000 attendees, exhibitors and sponsors.

The 20th Global Hepatitis Summit (GHS)  is celebrating their 50-year legacy on the International Symposium on Viral Hepatitis and Liver Disease (ISVLD). GHS 2027 will feature the latest developments in viral hepatitis, along three distinct tracks basic/translational, clinical, and public health.

The Canadian Liver Meeting is CASL's annual national conference highlighting the latest updates in research and clinical practice targeted to members of the Canadian hepatology community.

The 19th International Congress on Circumpolar Health will bring together researchers, healthcare professionals, and community leaders to advance health across circumpolar regions. The congress will feature scientific sessions on infectious diseases, liver disease, and hepatocellular carcinoma, alongside opportunities for international collaboration. The two-day pre-congress meeting will focusd on HIV, hepatitis C, sexually transmitted infections, and research governance.

The EASL Congress is Europe's largest event dedicated to liver health, where doctors, scientists, allied health professionals, patients and industry partners join to exchange knowledge.

World Hepatitis Day is an annual global awareness campaign led by the World Hepatitis Alliance to raise awareness of viral hepatitis and promote its prevention, diagnosis, treatment, and elimination. The campaign brings together healthcare professionals, researchers, policymakers, and communities to address stigma, improve access to care, and advance the global goal of eliminating viral hepatitis as a public health threat by 2030.

The International HBV Meeting will feature cutting edge studies in hepatitis B and D, discussions on the latest therapeutic development, an a platform for trainees to showcase their research